Yokogawa Acquires Fluence Analytics, a Pioneer in Digitalizing the Monitoring of Polymerization Reaction Processes

Enabling continuous real-time monitoring of polymers and biopolymers: Gamechanger for the polymer and biopharmaceutical industry

14-Mar-2023 - USA

Yokogawa Electric Corporation announces the acquisition of Fluence Analytics, Inc., a US-based startup that provides real-time analytics solutions to polymer and biopharmaceutical companies worldwide. Since signing investment and collaboration agreements in August 2021, the two companies have been exploring potential business opportunities. Through this acquisition, Fluence Analytics will integrate its operations with Yokogawa's existing business and further enhance its technological capabilities. Starting today, Fluence Analytics will operate as Yokogawa Fluence Analytics.

Computer-generated image

Symbolic image

Fluence Analytics is a global leader in polymerization reaction monitoring and control, and its automatic continuous online monitoring of polymerizations (ACOMP) product is the only commercially available system that can measure and analyze multiple polymer properties in real time. ACOMP's data streams provide new insights into material properties that enable customers to optimize and control polymerization processes, leading to improved product quality, greater yields, and less energy consumption and material waste. Based on the average size of a polymer reactor, the ACOMP system is estimated to deliver US$1.5 million in value per year.

Initial agreements between the two companies in August 2021 generated strong interest from global chemical companies seeking to transform their operations with automated digital technologies. Fluence Analytics is currently developing the next-generation ACOMP product, which will become part of Yokogawa's OpreX offering. The two companies are exploring how to integrate the next-generation ACOMP with Yokogawa's advanced control solutions and the digital technologies of KBC, another Yokogawa Group company. Yokogawa's global network will perform engineering and system integration tasks and provide after-sales field services for the ACOMP system.

Kenji Hasegawa, a Yokogawa Electric vice president and head of the Yokogawa Products Headquarters, commented, “Polymers are used in nearly every aspect of modern society in the form of plastics, rubber, paint, and so on. Combining Fluence Analytics' ACOMP system and other technology with our industry know-how will enable us to work with our customers to digitalize and automate polymerization processes that are currently monitored and adjusted manually. This will assist customers to improve worker safety, profitability, and environmental performance. We also plan to apply this technology to polymer re-use. We believe this is truly a game-changer for the industry.”

In addition to ACOMP, the Fluence Analytics product portfolio includes an innovative lab instrument designed to dramatically accelerate and optimize the development of novel biotherapeutics. The instrument enables the rapid assessment and real-time monitoring of the stability of therapeutic proteins, peptides, and other biopolymers under various thermal, mechanical, and chemical stress conditions.

“Combining forces with Yokogawa Electric enables us to capture the full value of our unique data sets, and we can't wait to deliver this added value to our customers. Together, we will enable autonomous operations and digital transformation in the polymer and biopharma industries,” says Jay Manouchehri, CEO of Yokogawa Fluence Analytics.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.